A randomized, double-blind study of GT267-004 versus vancomycin, and GT267-004 versus metronidazole in patients with C. difficile-associated diarrhea

Trial Profile

A randomized, double-blind study of GT267-004 versus vancomycin, and GT267-004 versus metronidazole in patients with C. difficile-associated diarrhea

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Tolevamer (Primary) ; Metronidazole; Vancomycin
  • Indications Clostridium infections; Diarrhoea
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms PACT
  • Sponsors Sanofi
  • Most Recent Events

    • 09 Nov 2012 Lead trial centre identified as reported by EudraCT.
    • 19 Apr 2008 Results presented at ECCMID 2008
    • 17 Aug 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top